DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Chapple CR, Rechberger T, Al-Shukri S. et al.
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.
BJU Int 2004;
93: 303-310
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.